News

PhD

ValiRc plc - Inaphaea BioLabs Subsidary Awarded HEIF Funding and PhD Sponsorship

ValiRx plc & Ambrose update on VAL401.

Update on proposed sub-license of VAL401

ValiRx plc - Engage Investor Presentation October 2024

Events and presentations

ValiRx plc - Engage Investor Webinar with Presentation and Q&A.

Investor ValiRx Webinar October 21st, 2024.

Events and presentations

ValiRx plc - Investor Webinar with Presentation and Q&A.

BioRep Co-Marketing Agreement

ValiRx plc - Co-Marketing Agreement Signed with BioRep

ValiRx plc Shard Investor Evening

Events and presentations

ValiRx plc - Company Vision Going Forward

ValiRx plc signs co-marketing agreement with Ignota Labs

ValiRx plc - Co-Marketing Agreement Signed with Ignota Labs.

Xenopat Agreement Signed

ValiRx plc - New Evaluation & Commercial Agreement Signed with Xenopat.

Co-Marketing Agreement with Spanios.

ValiRx plc - Co-Marketing Agreement Signed with Spanios LLC, USA.

ValiRx plc Shard Investor Evening

Events and presentations

ValiRx plc - CEO Dr Mark Eccleston to Present Company Vision Going Forward

ValiRx AGM 2024

Events and presentations

ValiRx AGM 2024

ValiRx - Live Q&A Webinar with Presentation Held 3rd June 2024

Videos and audiocasts

ValiRx Plc - Live Q&A Webinar with Presentation Held 3rd June 2024

News roundup

ValiRx news round-up: March 2024

ValiRx plc - Signed Evaluation Agreement with Imperial College London

Videos and audiocasts

ValiRx plc - Signed Evaluation Agreement with Imperial College London